YOLFTbeta
30

Nanjing Hicin Pharmaceutical Co Ltd

300584 · SHE · Healthcare / Drug Manufacturers - Specialty & Generic

29.95CNY-1.34 (-4.28%)

Price History

Full chart

Market Stats

Previous Close31.29
Open31.24
Day Range29.81 – 31.44
52-Week Range27.68 – 73.22
Volume3.15M
Market Cap3.74B
P/E (TTM)84.27
Forward P/E0.00
EPS0.37
Dividend Yield0.32%
Beta0.07
50-Day Avg32.20
200-Day Avg39.73

About

Nanjing Hicin Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of chemical preparations, APIs, and intermediates. The company's products include landiolol hydrochloride, rivaroxaban, tigecycline, torasemide, cefuroxime sodium, ceftriaxone hydrochloride, ganciclovir sodium, adenosine monophosphate, and adenosine monophosphate for injection; voglibose tablets, lansoprazole enteric-coated tablets, amlodipine besylate tablets, and glucosamine sulfate effervescent tablets; and raw materials, intermediates, and other products. Its products are used in cardiovascular and cerebrovascular, diuretic, anti-infection, digestive system, immune regulation, hypoglycemic, orthopedics, and other treatment areas. Nanjing Hicin Pharmaceutical Co., Ltd. was founded in 2003 and is headquartered in Nanjing, China.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMr. Yuping Cao
  • Employees553
  • HeadquartersNo.1 Hengfa Road, Nanjing, China, 210046, China
  • Websitehttps://www.hicin.cn

Leadership

  • Mr. Yuping CaoGM & Chairman of the Board · b. 1964
  • Mr. Mingsheng FengDeputy GM & Director · b. 1978
  • Mr. Li Qun WangSecretary & Deputy GM · b. 1988
  • Mr. Jian Ren ChenFinancial Director · b. 1969
  • Xiaowei LiAccounting Supervisor
  • Mr. Guangyao LiuDeputy General Manager · b. 1989
  • Mr. Wei Biao YueDeputy General Manager · b. 1970

Financials

Income Statement

Currency: CNY2012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue147.95M169.50M197.66M220.99M280.83M455.03M711.91M924.54M706.30M578.32M526.47M517.83M504.36M671.05M
Growth (%)-+14.56%+16.61%+11.81%+27.08%+62.03%+56.45%+29.87%-23.61%-18.12%-8.97%-1.64%-2.60%+33.05%
Cost of Revenue69.98M74.06M79.47M85.23M92.11M99.83M98.97M189.78M174.61M109.93M133.79M101.28M93.07M117.35M
Gross Profit77.97M95.44M118.18M135.76M188.72M355.20M612.94M734.76M531.69M468.39M392.68M416.56M411.29M553.69M
Gross Margin52.70%56.31%59.79%61.43%67.20%78.06%86.10%79.47%75.28%80.99%74.59%80.44%81.55%82.51%
Operating Expense47.85M58.05M78.13M90.29M136.64M277.61M516.42M620.49M469.18M137.09M362.57M377.26M369.48M463.96M
Operating Income30.13M37.40M40.05M45.47M52.08M77.59M96.52M114.27M62.51M331.30M30.10M39.29M41.81M89.73M
Operating Margin20.36%22.06%20.26%20.58%18.55%17.05%13.56%12.36%8.85%57.29%5.72%7.59%8.29%13.37%
EBITDA27.88M42.98M51.91M60.12M66.96M91.56M116.85M147.88M99.90M374.94M84.18M99.57M103.07M118.49M
EBITDA Margin18.84%25.36%26.26%27.20%23.85%20.12%16.41%15.99%14.14%64.83%15.99%19.23%20.44%17.66%
Net Income25.59M33.29M34.21M40.33M45.24M65.60M83.22M97.26M55.23M285.88M32.45M36.32M40.22M42.06M
Net Income Margin17.30%19.64%17.31%18.25%16.11%14.42%11.69%10.52%7.82%49.43%6.16%7.01%7.97%6.27%
R&D12.44M12.51M15.95M18.23M23.63M31.35M37.53M36.10M31.88M21.70M18.22M46.63M60.98M40.46M
R&D as % of Total Revenue8.41%7.38%8.07%8.25%8.41%6.89%5.27%3.90%4.51%3.75%3.46%9.01%12.09%6.03%
Interest Expense847.64K305.39K1.96M1.75M1.81M1.17M4.12M6.03M7.06M7.55M7.34M8.34M9.20M6.66M
Interest Expense % of Total Revenue0.57%0.18%0.99%0.79%0.65%0.26%0.58%0.65%1.00%1.31%1.39%1.61%1.82%0.99%

Balance Sheet

Currency: CNY2012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets190.67M241.42M293.78M322.63M370.78M632.30M794.19M869.18M906.52M1.30B1.29B1.41B1.46B1.53B
Total Liabilities58.03M75.49M93.63M87.55M94.66M114.61M213.26M215.19M227.55M353.53M343.38M421.37M426.37M432.26M
Total Equity132.65M165.93M200.15M235.08M276.11M517.68M580.93M654.08M679.77M950.33M950.57M987.50M1.02B1.05B
Cash29.46M38.62M29.60M44.00M24.50M74.58M100.77M150.10M103.23M115.60M95.07M46.82M45.76M66.19M
Total Debt18.00M22.00M39.70M37.70M32.40M42.60M119.50M124.17M170.19M180.28M178.15M252.98M302.56M-
Net Debt-11.46M-16.62M10.10M-6.30M7.90M-31.98M18.73M-25.93M66.97M64.68M83.09M206.16M256.80M175.24M

Cash Flow

Currency: CNY2012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow38.77M45.16M24.29M53.90M37.74M46.56M77.21M97.28M73.39M59.94M-5.82M23.93M59.96M78.09M
Investing Cash Flow-68.03M-41.81M-42.58M-29.85M-45.63M-182.11M-103.76M-22.68M-129.60M-85.57M29.12M-137.27M-77.93M-
Financing Cash Flow41.83M2.70M12.19M-9.65M-11.61M185.64M52.73M-25.46M9.01M37.08M-42.03M65.07M16.91M-
Capital Expenditure68.03M41.61M29.07M28.63M45.63M66.52M76.67M43.36M120.10M94.41M218.94M197.22M77.94M62.64M
Free Cash Flow-29.26M3.56M-4.78M25.27M-7.89M-19.96M538.35K53.91M-46.71M-34.47M-224.76M-173.29M-17.98M15.45M
Dividends Paid7.36M1.30M2.21M7.65M6.31M25.12M24.17M24.00M30.00M15.00M30.00M6.47M13.85M19.50M
FCF to OCF-75.47%7.88%-19.66%46.88%-20.91%-42.87%0.70%55.42%-63.65%-57.51%3862.31%-724.07%-29.98%19.78%
Dividend Paid to FCF-25.14%36.62%-46.31%30.29%-79.97%-125.82%4490.07%44.51%-64.22%-43.52%-13.35%-3.73%-77.05%126.25%

Earnings

Report DateApr 20, 2017Jul 15, 2017Oct 10, 2017Feb 6, 2018Apr 26, 2018Jul 30, 2018Oct 24, 2018Feb 26, 2019Apr 11, 2019Aug 2, 2019Oct 22, 2019Feb 25, 2020Apr 20, 2020Aug 17, 2020Oct 29, 2020Apr 7, 2021Aug 4, 2021Oct 26, 2021Apr 22, 2022Aug 26, 2022Oct 26, 2022Apr 25, 2023Aug 23, 2023Oct 27, 2023May 15, 2024Aug 23, 2024Oct 26, 2024May 15, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate---------------------------------
EPS Actual0.070.180.140.160.140.200.180.170.190.250.210.170.140.160.100.060.060.060.110.040.020.100.060.020.120.090.030.130.120.030.080.140.12
Surprise---------------------------------
TimingAfter-hoursAfter-hoursAfter-hoursPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketAfter-hoursPre-market--------After-hours--After-hours-----

Key Statistics & Ratios

Market Cap3.74B
Enterprise Value4.01B
Trailing P/E84.27
Forward P/E0.00
Price / Sales5.15
Price / Book3.50
EPS0.37
Book Value8.95
Revenue (TTM)726.62M
Gross Profit (TTM)550.29M
EBITDA164.32M
Profit Margin6.19%
Operating Margin13.25%
Return on Equity4.11%
Return on Assets3.89%
Shares Outstanding120.00M
Shares Float52.42M
Beta0.07
Dividend Yield0.32%
Dividend Rate0.10
Payout Ratio26.69%

Dividends

20261×
0.10Jun 25, 2026
20251×
0.10Jun 9, 2025
20241×
0.05Jun 18, 2024
20221×
0.25May 25, 2022
20211×
0.13May 13, 2021
20201×
0.25May 14, 2020
20191×
0.20May 7, 2019
20181×
0.17Apr 20, 2018
20171×
0.20Jun 8, 2017

Stock Splits

  • Apr 20, 20181.5:1